Azenta, Inc. (AZTA) vs Anbio Biotechnology (NNNN)

Azenta, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. Azenta, Inc. is the larger, with a market value of $1.5B against $884.9M — 1.7× the size. Across the 8 metrics below, Anbio Biotechnology leads on 5 and Azenta, Inc. on 3.

Valuation

Metric AZTA NNNN Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 2.51 — 2.83
P/B 1.02 n/m 2.82
Price to free cash flow 155.92 n/m 25.69
EV/EBITDA 45.72 n/m 16.08
EV/Sales 2.09 n/m 3.06
Earnings yield (8.08%) — (1.84%)
Free cash flow yield 0.64% 0.00% 0.17%

Profitability

Metric AZTA NNNN Medical Instruments & Supplies median
Gross margin 44.05% — 54.62%
Operating margin (28.56%) — 1.64%
Net margin (20.02%) — 0.00%
Free cash flow margin 1.61% 0.00% 1.61%
Return on equity (7.72%) 0.00% 0.00%
Return on assets (6.31%) 0.00% 0.00%
Return on invested capital (9.27%) 0.00% 0.00%

Growth

Metric AZTA NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 4.80% — 9.20%
EPS growth (last fiscal year) 57.93% 150.00% —
Revenue growth, 5-year CAGR 8.85% — 9.48%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AZTA NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 2.50 344.45 2.49
Net debt to EBITDA (10.47) (2.06) 0.83

Dividend

Metric AZTA NNNN Medical Instruments & Supplies median
Dividend yield 0.55% — 0.99%
Payout ratio 0.00 — 0.00

Size

Metric AZTA NNNN Medical Instruments & Supplies median
Market cap 1.50b 884.93m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack